Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Biocon Launches Haselmeier's Insulin Pen in India

Published 15 March 2012 | By Haselmeier

Haselmeier has announced that Biocon, one of Asia's premier biotechnology companies, has launched INSUPen® in India. Under the terms of the agreement between the two companies, Biocon has worldwide distribution rights to INSUPen, for use with Biocon's insulin and insulin analogues. The first launch of the INSUPen has taken place with Biocon's Basalog® and Insugen® insulins.

Available Downloads

Biocon Launches Haselmeier's Insulin Pen in India